Online inquiry

IVTScrip™ mRNA-Human ARHGAP26, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK24991MR)

This product GTTS-WK24991MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARHGAP26 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001135608.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 23092
UniProt ID Q9UNA1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARHGAP26, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK24991MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16467MR IVTScrip™ mRNA-Human ANXA8L1, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA8L1
GTTS-WK9497MR IVTScrip™ mRNA-Human ADAM9, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAM9
GTTS-WK14003MR IVTScrip™ mRNA-Human ADAMTS4, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAMTS4
GTTS-WK11033MR IVTScrip™ mRNA-Human ADGRB2, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRB2
GTTS-WK5721MR IVTScrip™ mRNA-Human Go-alpha, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Go-alpha
GTTS-WK11336MR IVTScrip™ mRNA-Human ADGRE1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADGRE1
GTTS-WK13738MR IVTScrip™ mRNA-Human ADGRE3, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ADGRE3
GTTS-WK11682MR IVTScrip™ mRNA-Human AFF1, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AFF1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →